Loading...

NEW COVID LONG-HAUL ANNOUNCEMENT

HEALTH CANADA: Dolphin Vagal Nerve Stimulator has now been authorized for home or clinical use by Health Canada to treat COVID-19 LONG-HAUL symptoms and/or asthma-related reduced airflow, using non-invasive VNS applied to the auricular branch of the vagus nerve (ABVN).

Note: Starting March 19, 2024, Health Canada will be rescinding the expanded use indications granted during the COVID-19 pandemic as there is no longer an urgent public health need for devices related to COVID-19.

Dolphin Vagal Nerve Therapy

Dolphin Vagal Nerve Stimulation (VNS) is a promising new therapy to combat the lingering adverse effects patients are experiencing with COVID long-haul symptoms.

Dolphin VNS is a safe procedure that may be administered in a home or clinical setting and may be applied under fifteen minutes (<15 minutes).

Vagus nerve stimulation (VNS), an emerging field of bioelectronic medicine, is now supported in science as a viable therapy for the treatment of many stress-related disorders.

This potent relaxation therapy has been published in science to provide the same relaxation as eight (8) 1-hour massages in less than 10 minutes.

VAGUS NERVE IMPORTANCE

The two branches of the Vagus Nerve (VN) are part of the autonomic nervous system and are considered the “brakes” of the body. This 10th cranial nerve is so important, it is responsible for our immunity, anti-inflammatory, and respiratory functioning.

Stress is a killer, as the leading cause of 90% of human deaths is stress-related conditions (Salleh 2008). So activating and maintaining a strong and vibrant vagus nerve is much more important than most people realize.

NEW FIELD of Medicine: Vagus nerve stimulation (VNS), an emerging field of bioelectronic medicine, has been proven to regulate inflammatory responses and is supported in science as a promising therapy for the treatment of COVID-19 Long-Haul symptomology (Azabou et al, 2021).

COVID LongHaulers

COVID Long-Haulers suffer from stress-activated diseases caused by COVID-19’s negative influence on the vagus nerve. Long-Haul symptoms can continue to plague people, even months after initial infection with the virus.

COVID Long-Haulers face a bleak future of long-term issues with fatigue, anxiety, dizziness, chest pains, and digestion problems that often can take a dramatic toll on their quality of life.

GOOD NEWS! Vagus nerve stimulation (VNS is supported in science as a promising new therapy for treating COVID-19 Long-Haul symptomology. (Azabou et al, 2021)

“I am amazed this treatment has given back some of the “normal” that I had lost due to COVID. This technology is brilliant, thank you”. Joan C.